Time to Diagnosis of Duchenne Muscular Dystrophy Patients With or Without Development Delay
Journal of Child Neurology · 2026
DOI: 10.1177/08830738251346285 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Child Neurology, 2026. Verfasst von Marco Antônio Veloso de Albuquerque und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, Brazil. Hauptthemen laut MEDLINE: Muscular Dystrophy, Duchenne, Developmental Disabilities, Delayed Diagnosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Introduction
Duchenne muscular dystrophy, the most common inherited neuromuscular disease in children, typically presents its first symptoms at 3-5 years of age with progressive muscular weakness. However, in some boys, the disease manifests earlier in childhood with developmental delays, such as delays in walking and speech, or signs of an autism spectrum disorder.
Objective
To analyze and compare the age and time until diagnosis in boys with Duchenne muscular dystrophy, with or without developmental delays as the first sign of disease. Material and Methods This is a retrospective descriptive study. Data were collected from 127 boys with Duchenne muscular dystrophy who were followed at the Outpatient Muscle Clinic of Hospital das Clínicas (FMUSP/SP) from 2015 to 2024. To determine the age and time interval between symptom onset and diagnosis, we analyzed the total sample, and 3 separate groups based on initial symptoms.
Results
In the total sample, the mean age of diagnosis was 6.9 years, with an average interval of 3.6 years between symptom onset and diagnosis. In patients with developmental delays, initial symptoms were observed at an average age of 1.4 years, and despite a diagnosis delay of 3.4 years, these patients were diagnosed an average of 2.7 years earlier than those with normal development.
Conclusion
Our findings suggest that Duchenne muscular dystrophy should be considered in the differential diagnosis of boys presenting with developmental delays (motor, speech, or cognitive). In such cases, screening with creatine kinase level measurements is crucial.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, Brazil.
ORCID-Profile: Marco Antônio Veloso de Albuquerque, Karla Danielle Lima, Fernando Kok, Edmar Zanoteli
Zitieren
APA
Albuquerque, M. A. V., Lima, K. D., Kok, F., & Zanoteli, E. (2026). Time to Diagnosis of Duchenne Muscular Dystrophy Patients With or Without Development Delay. Journal of Child Neurology. https://doi.org/10.1177/08830738251346285
Vancouver
Albuquerque MAV, Lima KD, Kok F, Zanoteli E. Time to Diagnosis of Duchenne Muscular Dystrophy Patients With or Without Development Delay. Journal of Child Neurology. 2026. doi:10.1177/08830738251346285
BibTeX
@article{Albuquerque2026,
author = {Albuquerque, Marco Antônio Veloso de and Lima, Karla Danielle and Kok, Fernando and Zanoteli, Edmar},
title = {Time to Diagnosis of Duchenne Muscular Dystrophy Patients With or Without Development Delay},
journal = {Journal of Child Neurology},
year = {2026},
doi = {10.1177/08830738251346285}
}
EUVIMED